Latest Insider Transactions at Hille Vax, Inc. (HLVX)
This section provides a real-time view of insider transactions for Hille Vax, Inc. (HLVX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HilleVax, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HilleVax, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2025
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
6,724,000
-100.0%
|
$6,724,000
$1.95 P/Share
|
|
Sep 17
2025
|
Frazier Life Sciences X, L.P. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
8,552,536
-100.0%
|
$8,552,536
$1.95 P/Share
|
|
Sep 17
2025
|
Shane Maltbie Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
83,738
-100.0%
|
-
|
|
Sep 17
2025
|
Jaime Sepulveda |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
59,224
-100.0%
|
-
|
|
Sep 17
2025
|
Julie L. Gerberding |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
59,224
-100.0%
|
-
|
|
Sep 17
2025
|
Aditya Kohli |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
698,171
-100.0%
|
-
|
|
Sep 17
2025
|
Gary Dubin |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
17,199
-100.0%
|
-
|
|
Sep 17
2025
|
Shelley Chu |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
17,199
-100.0%
|
-
|
|
Sep 17
2025
|
Jeryl L Hilleman |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
59,224
-100.0%
|
-
|
|
Sep 17
2025
|
Nanette Cocero |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
17,199
-100.0%
|
-
|
|
Sep 17
2025
|
Robert Hershberg President and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,101,498
-100.0%
|
-
|
|
Jun 23
2025
|
Patrick J Heron |
BUY
Grant, award, or other acquisition
|
Direct |
17,199
+50.0%
|
-
|
|
Jun 23
2025
|
Aditya Kohli |
BUY
Grant, award, or other acquisition
|
Direct |
17,199
+2.4%
|
-
|
|
Jun 23
2025
|
Shelley Chu |
BUY
Grant, award, or other acquisition
|
Direct |
17,199
+50.0%
|
-
|
|
Jun 23
2025
|
Jaime Sepulveda |
BUY
Grant, award, or other acquisition
|
Direct |
17,199
+22.51%
|
-
|
|
Jun 23
2025
|
Gary Dubin |
BUY
Grant, award, or other acquisition
|
Direct |
17,199
+50.0%
|
-
|
|
Jun 23
2025
|
Julie L. Gerberding |
BUY
Grant, award, or other acquisition
|
Direct |
17,199
+22.51%
|
-
|
|
Jun 23
2025
|
Nanette Cocero |
BUY
Grant, award, or other acquisition
|
Direct |
17,199
+50.0%
|
-
|
|
Jun 23
2025
|
Jeryl L Hilleman |
BUY
Grant, award, or other acquisition
|
Direct |
17,199
+22.51%
|
-
|
|
Feb 11
2025
|
Shane Maltbie Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,345
-5.16%
|
$4,345
$1.76 P/Share
|
|
Feb 11
2025
|
Robert Hershberg President and CEO |
SELL
Open market or private sale
|
Direct |
11,901
-1.07%
|
$11,901
$1.76 P/Share
|
|
Feb 04
2025
|
Shane Maltbie Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,946
-4.48%
|
$3,946
$1.89 P/Share
|
|
Feb 04
2025
|
Robert Hershberg President and CEO |
SELL
Open market or private sale
|
Direct |
14,634
-1.3%
|
$14,634
$1.89 P/Share
|
|
May 22
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.78%
|
$84,000
$14.73 P/Share
|
|
May 21
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.77%
|
$84,000
$14.21 P/Share
|
|
May 20
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.77%
|
$90,000
$15.45 P/Share
|
|
May 03
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
723
-0.09%
|
$10,122
$14.15 P/Share
|
|
May 02
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.76%
|
$84,000
$14.01 P/Share
|
|
May 01
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
175
-0.02%
|
$2,450
$14.03 P/Share
|
|
Apr 05
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.75%
|
$84,000
$14.44 P/Share
|
|
Apr 04
2024
|
Frazier Life Sciences X, L.P. |
BUY
Open market or private purchase
|
Direct |
8,850
+0.1%
|
$123,900
$14.5 P/Share
|
|
Apr 04
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.75%
|
$84,000
$14.71 P/Share
|
|
Apr 03
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.74%
|
$84,000
$14.93 P/Share
|
|
Mar 28
2024
|
Sean Mc Loughlin Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
1,250
+50.0%
|
$20,000
$16.98 P/Share
|
|
Mar 20
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.74%
|
$985,326,000
$164221.0 P/Share
|
|
Mar 19
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.73%
|
$102,000
$17.42 P/Share
|
|
Mar 18
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.73%
|
$102,000
$17.66 P/Share
|
|
Mar 08
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.72%
|
$108,000
$18.66 P/Share
|
|
Mar 07
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.72%
|
$108,000
$18.37 P/Share
|
|
Mar 06
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.71%
|
$108,000
$18.95 P/Share
|
|
Feb 22
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.71%
|
$90,000
$15.05 P/Share
|
|
Feb 21
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.7%
|
$84,000
$14.92 P/Share
|
|
Feb 20
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.7%
|
$84,000
$14.88 P/Share
|
|
Feb 12
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.69%
|
$90,000
$15.32 P/Share
|
|
Feb 08
2024
|
Aditya Kohli |
BUY
Grant, award, or other acquisition
|
Direct |
54,898
+5.95%
|
-
|
|
Feb 08
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
8,866
-1.08%
|
$124,124
$14.93 P/Share
|
|
Feb 08
2024
|
Shane Maltbie Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,522
+35.02%
|
-
|
|
Feb 08
2024
|
Shane Maltbie Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,576
-8.08%
|
$50,064
$14.93 P/Share
|
|
Feb 08
2024
|
Robert Hershberg President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
174,202
+13.38%
|
-
|
|
Feb 08
2024
|
Robert Hershberg President and CEO |
SELL
Open market or private sale
|
Direct |
11,597
-1.2%
|
$162,358
$14.93 P/Share
|